Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Drik brings toxicology testing to state

Get in Touch

By Scott Meacham

Copyright © 2013, The Oklahoma Publishing Company

One of the reasons the innovation economy is such a kick-starter for jobs is that new companies in new industries lead to more new companies to support the new industries.

It’s a food chain, like when striking oil created a need for local companies to manufacture drill bits and casing pipe.

A perfect example of this effect is Drik LLC (www.atdrik.com), Oklahoma’s first toxicology lab. Drik brings toxicology safety testing directly to our state’s pharmaceutical and biotechnology industries.

With the growth of Oklahoma’s biotechnology sector, the need for toxicology testing for new drugs has grown accordingly. Toxicology testing is critically important to researchers, scientists and companies who are working to develop new drugs. Safety is paramount.

Long before new solutions can even approach coming market, they must be thoroughly tested for possible adverse effects on people and the environment. Food and Drug Administration requirements are stringent and specific.

Another important reason for extensive toxicology testing is that companies often have multiple drugs for a given disease under development. The earlier and more effectively they can determine which drug has the most potential to overcome toxic effects, the better firms can prioritize their research and resources to deliver treatments for disease.

The benefits that Drik brings to Oklahoma as its first toxicology lab are twofold. The firm offers slice culture testing, a significantly superior technique than cell culture testing that many toxicology labs perform.

“There are over 100,000 regulated chemicals available in the market, and the full toxic effects are known for less than 10 percent,” said Kumar Sripathirathan, Ph.D., Drik founder and CEO.

“Slice cultures give a more true picture of what is actually happening with the drug,” he said. “Additionally, they remain viable for over a month while cell cultures lose their characteristics after several days.”

Drik’s second great benefit is one of proximity. It takes extra time and money for an Oklahoma company to investigate and audit a toxicology facility outside our borders — not to mention the challenges of building strong business partnerships with people who are hundreds or even thousands of miles away.

Having Drik on the ground in Oklahoma will speed the process and create immediate synergy. The firm has identified many companies, foundations and universities within a 500-mile radius that are likely candidates for toxicology services. It is good to finally have an Oklahoma toxicology lab available for our growing bioscience sector.

Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology. Contact Meacham at i2E_Comments@i2E.org.

DID YOU KNOW?  U.S. regulators approved 39 new drugs in 2013, the most since 1996 when 53 so-called new molecular entities were approved. SOURCE: Reuters

Click here to read the article at newsok.com

Author

  • admin admin

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E